Results 21 to 30 of about 57,804 (333)
Immunotherapy for thymoma [PDF]
Journal of Thoracic Disease, 2020 Thymic epithelial tumors (TETs) are rare thymic neoplasms. There are approximately 1.5 cases per million TETs per year. They are the most common anterior mediastinal tumors in adults. Due to limited activity of available treatment options novel strategies and treatment options are needed and treatment with immune checkpoint inhibitors is an attractive ...
Kristina Krpina +7 more
openaire +2 more sources
Frontiers in Oncology, 2022 ObjectivesAccurate histological typing plays an important role in diagnosing thymoma or thymic carcinoma (TC) and predicting the corresponding prognosis.
Huaqi Zhang +7 more
doaj +1 more source
Viral infection in thymoma and thymic tumors with autoimmune diseases
Thoracic Cancer, 2021 A thymoma is a type of thymic tumor which is rarely malignant that is frequently reported in adult patients. A number of thymoma‐related immune disorders are observed including autoimmune diseases, which suggests a strong connection between thymoma ...
Rui Chang +3 more
doaj +1 more source
Expression and Diagnostic Value of NPTX1 in Thymoma Patients
Chinese Journal of Lung Cancer, 2021 Background and objective Thymomas are the most common primary malignant tumors of anterior mediastinal. However, there are no specific laboratory indicator for the diagnosis the diagnosis of thymoma. The aim of this study was to screen out a tumor marker
Xin DU +4 more
doaj +1 more source
Analysis of Gene Variation in Thymoma by Microarray
Chinese Journal of Lung Cancer, 2020 Background and objective Thymoma is the most common malignant tumor in anterior mediastinum, and its specific pathogenesis is still unclear. This limits the study of targeted drugs for thymoma.
Lijun WANG, Lei YU, Xin DU, Chengyu HUO
doaj +1 more source
Real‐world study of treatment and outcome of type B2 + B3 thymoma: The neglected part of thymoma
Thoracic Cancer, 2023 Background This study aimed to examine the treatment and prognosis of patients with type B2 + B3 thymoma and compare it with those patients with type B2 and B3 thymoma. Methods We conducted a retrospective analysis of the results of 39 patients with type
Ke Zhao +13 more
doaj +1 more source
Mediastinal Tumor Thymoma Type B1 T4N2M1B Stage IVB with Multimodality Therapy [PDF]
, 2022 The incidence of thymoma increases with age, generally occurs in the 40-60s. Thymoma cases are rare at a young age. The prevalence of thymoma at a young age is very small at 0.6 – 5% of all thymoma cases. Thymoma management requires multimodality therapy
Afriani, Afriani +2 more
core +2 more sources
Thymoma-Related Paraneoplastic Syndrome Mimicking Reactive Arthritis
Medicina, 2021 Background and Objectives: Thymomas are associated with a high frequency of paraneoplastic manifestations. Paraneoplastic syndrome (PNS) with thymoma presents a challenge to clinicians because of the need to decipher the association between the ...
Chang-Hung Liao +4 more
doaj +1 more source
Conflicting or complementary role of computed tomography (CT) and positron emission tomography (PET)/CT in the assessment of thymic cancer and thymoma: Our experience and literature review [PDF]
, 2015 Background: To evaluate the role of computed tomography (CT) and positron emission tomography (PET)/CT in patients with thymic cancer and thymoma at initial staging.
Calabrese, Fiorella +6 more
core +1 more source
Cyclosporine is a potential curative treatment option for advanced thymoma
Experimental Hematology & Oncology, 2017 Background Thymectomy can effectively cure most thymoma patients; however, patients with advanced thymoma typically require chemotherapy, which is associated with limited efficacy in this context.
Yusuke Isshiki +3 more
doaj +1 more source